Seres Therapeutics, Inc. (MCRB)
NASDAQ: MCRB · Real-Time Price · USD
7.09
-0.23 (-3.14%)
At close: Apr 28, 2026, 4:00 PM EDT
7.11
+0.02 (0.28%)
After-hours: Apr 28, 2026, 6:01 PM EDT
Seres Therapeutics Employees
Seres Therapeutics had 66 employees as of December 31, 2025. The number of employees decreased by 37 or -35.92% compared to the previous year.
Employees
66
Change (1Y)
-37
Growth (1Y)
-35.92%
Revenue / Employee
$11,955
Profits / Employee
$86,303
Market Cap
67.97M
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Fortress Biotech | 78 |
| Acrivon Therapeutics | 76 |
| ImmuCell | 73 |
| Pliant Therapeutics | 49 |
| MAIA Biotechnology | 13 |
| Actuate Therapeutics | 12 |
| MediciNova | 6 |
| OS Therapies | 5 |
MCRB News
- 8 days ago - Seres Therapeutics Showcases SER-155 Data and Live Biotherapeutic Insights at ESCMID Global 2026 - GlobeNewsWire
- 19 days ago - Seres Therapeutics to Present at CARB-X Investor Day - GlobeNewsWire
- 6 weeks ago - Seres Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates - GlobeNewsWire
- 2 months ago - Seres Therapeutics Transcript: Status update - Transcripts
- 2 months ago - Seres Therapeutics Announces Appointment of Richard N. Kender as Executive Chair and Interim CEO; Provides Business Updates - GlobeNewsWire
- 2 months ago - Seres Therapeutics Pauses Key Drug Study, Cuts Jobs To Save Cash - Benzinga
- 2 months ago - Seres Provides Program and Corporate Updates and Prioritizes Emerging Programs in Inflammatory & Immune Diseases - GlobeNewsWire
- 4 months ago - Seres Therapeutics Announces Publications in Nature Medicine and Journal of Infectious Diseases Highlighting Vowst™ Mechanism of Action and Supporting Broader Live Biotherapeutic Strategy - GlobeNewsWire